Subscribe To
Memecoin mooky raises $900,000 ahead of its final presale stage
Memecoin Mooky is gearing up for its final presale phase, having raised $900,000 to date. More than just a ...
June 30, 2023, 11:39 am
The cashless society: a paradigm shift in financial transactions
In recent years, there has been a substantial shift in the way we perform financial transactions. The development of digital payment methods and the i...
June 29, 2023, 12:57 pm
Regtech innovations: transforming compliance in the digital age
Regulatory compliance has become a challenging task for organizations across industries in today's quickly expanding digital landscape. The emergence ...
June 28, 2023, 2:12 pm
Axsome therapeutics announces proposed public offering of common stock
NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM) (“Axsome” or the “Company”), a biopharmaceutical company...
June 28, 2023, 12:24 am
The privacy layer for web3, iron fish, launches node application, enabling privacy-conscious users to run a full node in one click
SAN FRANCISCO, June 27, 2023 (GLOBE NEWSWIRE) — Iron Fish, a fully private, proof-of-work (PoW) based layer 1 blockchain with built-in compliance fe...
June 27, 2023, 2:30 pm
Amyotrophic lateral sclerosis treatment market to reach us$ 594.1 million in 2031, expanding at a cagr of 5.5%: tmr report
Increased consumer and medical professional knowledge regarding novel treatments is predicted to drive ...
June 26, 2023, 5:30 pm
Enterin presents data demonstrating strong benefit of ent-03 on body weight, adiposity and blood glucose vs. semaglutide in a diet induced obesity mouse model
Data presented at the American Diabetes Association 83rd Scientific Sessions PHILADELPHIA, June 24, 2023 (GLOBE NEWSWIRE) — Enterin Inc., a privatel...
June 24, 2023, 12:00 pm
Pliant therapeutics presents data from its bexotegrast program at the european association for the study of the liver (easl) international liver congress™
Presentations highlight preclinical and clinical advancements of bexotegrast program in primary sclerosing cholangitis SOUTH SAN FRANCISCO, Calif., Ju...
June 23, 2023, 11:30 am
Disc medicine announces closing of public offering of common stock and pre-funded warrants including full exercise of underwriters’ option to purchase additional shares
WATERTOWN, Mass., June 22, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on ...
June 22, 2023, 8:15 pm
Mindset pharma's phase 2 psilocin prodrug study gets green light from uk regulators
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) has received approval from the UK Medicines and Healthcare products Regulatory Authority and the Research E...
June 22, 2023, 10:45 am
Nextcure presents non-clinical data defining the mechanism of nc525 at the 2023 federation of clinical immunology societies (focis) annual meeting
BELTSVILLE, Md., June 21, 2023 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering...
June 21, 2023, 8:05 pm
Biomerica receives notice of patent allowance in china for a potential innovative technology that includes an artificial intelligence (ai) claim for predicting foods that contain ingredients that caus
Patent Claims Describe a novel System to Predict and Help Prevent Adverse Food Reactions Using Personal...
June 21, 2023, 12:19 pm
Vaccitech to present positive final data at easl congress for phase 1b/2 hbv002 study in adults with chronic hepatitis b
OXFORD, United Kingdom, June 21, 2023 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the disc...
June 21, 2023, 9:03 am
Arbutus presents preliminary ab-729 and pegylated interferon alfa-2a combination data at the easl congress 2023
Treatment was generally well tolerated with continued HBsAg declines in some patients WARMINSTER, Pa., June 21, 2023 (GLOBE NEWSWIRE) — Arbutus Biop...
June 21, 2023, 6:01 am
Biomea fusion to present late breaking data from ongoing phase ii trial, covalent-111, evaluating bmf-219 in patients with type 2 diabetes at ada 2023
New clinical data from COVALENT-111 will be unveiled during a late-breaking poster presentation at ADA’s Scientific Sessions BMF-219, an orally deli...
June 20, 2023, 8:30 pm
Biomea fusion to present late breaking data from ongoing phase ii trial, covalent-111, evaluating bmf-219 in patients with type 2 diabetes at ada 2023
REDWOOD CITY, Calif., June 20, 2023 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company ...
June 20, 2023, 4:30 pm
Cognition therapeutics invited to participate on panel during cantor fitzgerald brain week 2023 on novel alzheimer’s disease approaches
PURCHASE, N.Y., June 20, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (Nasdaq: CGTX) (the “Company” or “Cognition”), announced today...
June 20, 2023, 11:30 am
Attovia therapeutics launches with $60 million series a financing to unlock potential of novel biparatopic nanobody platform
Company Formed by Alamar Biosciences and Frazier Life Sciences Attobody™ Platform Generates Small Format Binders for Hard-to-drug Targets FREMONT, C...
June 20, 2023, 11:30 am
Helius medical technologies announces dmepos accreditation for pons
— Critical initial step toward US reimbursement — NEWTOWN, Pa., June 20, 2023 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT)...
June 20, 2023, 11:05 am
Iovance biotherapeutics to host virtual roundtable with key opinion leaders to discuss melanoma treatment landscape
Investor Conference Call and Webcast on June 26 at 5:00 p.m. ET SAN CARLOS, Calif., June 20, 2023 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (...
June 20, 2023, 11:01 am